Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Cited by (846)

Items 501–600 of 846

1. Transcriptional regulation by LKB1 in lung adenocarcinomas: Exploring oxidative stress, neuroglial and amino acid signatures
   Marie Mével‐Aliset, Anca G. Radu, Jordan Allard, Sandrine Blanchet, Emilie Montellier, Pierre L. Hainaut, Rodrigue Rossignol, Sakina Torch, Guillermo A. Orsi, Chantal Thibert · 2025 · Biochemical and Biophysical Research Communications
2. Activating Cancer Hallmarks through Changes in mRNA/Protein Regulation
   Jose Humberto Giraldez Chavez, Nathaniel Barton, Caleb M. Lindgren, Bryn Mendenhall, Benjamin Kimball, Samuel H Payne · 2025 · Journal of Proteome Research
3. Intrinsic PDL1 Signaling Modulates TGFBI ‐Mediated Growth Suppression in Lung Adenocarcinoma
   Thi Thanh Nha Nguyen, Pei‐Yu Chen, Ming‐Yi Zheng, Ting‐Kuang Lin, Chun‐Chao Wang, Yuh‐Min Chen, Yu‐Ting Chou · 2025 · Cancer Science
4. Brain Somatic Variant in Ras-Like Small GTPase RALA Causes Focal Cortical Dysplasia Type II
   Xu Han, Kai Gao, Qingzhu Liu, Tianshuang Wang, Zhongbin Zhang, Lixin Cai, Ye Wu, Yuwu Jiang · 2022 · Frontiers in Behavioral Neuroscience
5. LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments
   Zu‐Xuan Chen, Liang Liang, Heqing Huang, Jian‐Di Li, Rong‐Quan He, Zhi‐Guang Huang, Rui Song, Gang Chen, Jian‐Jun Li, Zheng‐Wen Cai et al. · 2023 · Cancer Medicine
6. Proteomic analysis of acute radiation-induced rectal injury in rats
   Yue Zhu, Jun Dai, Xiaopeng Xu, Yi Gao, Weidong Shen, Shuyu Zhang, Pengfei Liu · 2023 · Radiation Medicine and Protection
7. An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)
   Ciaran Murphy, Glòria Gornés Pons, A. Keogh, Lisa Ryan, L. Mccarra, Chris Maria Jose, Shagun Kesar, S. Nicholson, G. Fitzmaurice, R. Ryan et al. · 2023 · Biomedicines
8. Identification of hypoxia‐related gene signatures based on multi‐omics analysis in lung adenocarcinoma
   Qineng Luo, Xing Li, Zixing Meng, Hao Rong, Yanguo Li, Guofang Zhao, Huangkai Zhu, Lvjun Cen, Qi Liao · 2023 · Journal of Cellular and Molecular Medicine
9. Hypomethylation‐associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation‐mediated degradation of SND1
   Qi Lai, Yulin Wan, Yingqian Zhang, Yingzhao Huang, Qiuyue Tang, Mei Chen, Qian Li, Ke Ma, Ping Xiao, Cheng Luo et al. · 2024 · Molecular Carcinogenesis
10. A heterogeneous tumor immune microenvironment of uncommon epidermal growth factor receptor mutant non‐small cell lung cancer
    Chong Zhang, Liangwei Yang, Weidi Zhao, Huangkai Zhu, Shuo Shi, Songan Chen, Guoqiang Wang, Bing Li, Guofang Zhao · 2024 · Cancer Science
11. The deubiquitinase USP9X regulates RIT1 protein abundance and oncogenic phenotypes
    Amanda K. Riley, Michael Grant, Aidan H. Snell, Elizabeth A. Cromwell, Athea Vichas, Sitapriya Moorthi, Callie Rominger, Shrikar P. Modukuri, Anatoly Urisman, Pau Castel et al. · 2024 · iScience
12. Identification of G protein subunit alpha i3 as a promising oncotarget of LUAD
    Gaomeng Luo, Wenxuan Hu, Jian Yang, Hao Ding, Chun Xu, Xin Tong, Cheng Ding, Jun Zhao · 2024 · Cellular Signalling
13. Mir-494-3p enhances aggressive phenotype of non-small cell lung cancer cells by regulating SET/I2PP2A
    Yuwen Du, Taisuke Kajino, Yukako Shimada, Takashi Takahashi, Ayumu Taguchi · 2025 · Scientific Reports
14. Online Tools for Teaching Cancer Bioinformatics
    Mason D. Taylor, Bryn Mendenhall, Calvin S. Woods, Madeline E. Rasband, Milene C. Vallejo, Elizabeth Gibbons Bailey, Samuel Payne · 2021 · Journal of Microbiology and Biology Education
15. Dual data and motif clustering improves the modeling and interpretation of phosphoproteomic data
    Marc Creixell, Aaron S. Meyer · 2022 · Cell Reports Methods
16. SLF1 polymorphism predicts response to oxaliplatin-based adjuvant chemotherapy in patients with colon cancer.
    Xiaohong Han, Zheng Wang, Lei Zhang, Yinchen Shen, Qiaoyun Tan, Yongkun Sun, Jianfei Wang, Xiaoyan Qian, Hongying Yang, Yuankai Shi · 2021 · PubMed Central
17. ZSWIM1 Promotes the Proliferation and Metastasis of Lung Adenocarcinoma Cells through the STK38/MEKK2/ERK1/2 Axis
    Xuejuan Gao, Qionghua Lian, Baiye Guan, Qiuyu Liu, Meng Meng, Yang Chen, Jingjie Jin, Hui‐Hua Li, Xiaohui Liu, Zhenghua Sun et al. · 2022 · Journal of Proteome Research
18. Deep computational analysis of human cancer and non-cancer tissues details dysregulation of eIF4F components and their interactions in human cancers
    Su Wu, Gerhard Wagner · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
19. Proteogenomic analysis of air-pollution-associated lung cancer reveals prevention and therapeutic opportunities
    Honglei Zhang, Chao Liu, Shuting Wang, Qing Wang, Feng Xu, Hua‐Wei Jiang, Yong Zhang, Xiaosan Su, Gaofeng Li · 2024 · eLife
20. LIMD1 Loss as an Early Driver of PD-L1 Upregulation and Immune Evasion in Lung Cancer
    Kunal M. Shah, Paul T. Kennedy, James R. Black, Kevin Litchfield, Krupa Thakkar, Maria F. Contreras-Gerenas, Kirsten Brooksbank, Oliver Yuan, Paul Grevitt, Sarah Charrot et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
21. The Pd (II) Reduction Mechanisms in Bacillus megaterium Y-4 Revealed by Proteomic Analysis
    Yuan Chen, Jiaxing Wang, Daidi Chen, Boxi Wang, Jinchuan Wu, Rongrong Liu, Qingxin Li · 2024 · Nanomaterials
22. An approach for developing a blood-based screening panel for lung cancer based on clonal hematopoietic mutations
    Ramu Anandakrishnan, Ryan Shahidi, Andrew Dai, Veneeth Antony, Ian J. Zyvoloski · 2024 · PLoS ONE
23. RASGEF1C as a novel prognostic biomarker for LUAD
    Jinlong Liu, Xiaoying Liu, Yingou Zeng, Di Qiao, Bin Dai, Yun‐Long Wu, Meng Wang, Qiang Wang · 2024 · Discover Oncology
24. Phosphorylation of syntenin-1 by TBK1 promotes proliferation and migration of non-small cell lung cancer cells
    Linbo Gao, Hecun Zou, Guojiao Xie, Xinning Li, Zan Chen · 2025 · Journal of Biological Chemistry
25. Revealing the significance of tissue-resident memory T cells in lung adenocarcinoma through bioinformatic analysis and experimental validation
    Zhuoqi Li, Mei Ling Tian, Yuanhui Yang, Yuanyuan Wang, Lu Zhang, Fujing Huang, Wen Xiao, Xiaoshu Yin, Xiaoyan Lin, Yuan Tian · 2025 · Frontiers in Immunology
26. SUMO-activating enzyme subunit 1 (SAE1) promotes non-small cell lung cancer metastasis by promoting the epithelial-mesenchymal transition through the SUMOylation of N-cadherin
    Yaru Wang, Xijun Wang, Huan Zhao, Jie Young Song, Wenhao Hou, Zhenrong Liu, Xin Yang, Sheng Ma, Ruiqi Zheng, Huiqin Guo et al. · 2025 · Science China Life Sciences
27. Glycoprotein-Notebook: A Pan-Cancer Glycoproteomic Database and Toolkit for Analysis of Protein Glycosylation Changes Associated With Cancer Phenotypes
    Hui Zhang, Trung Hoang, Yingwei Hu · 2025 · Molecular & Cellular Proteomics
28. Multi-omics analysis reveals comprehensive aberrant protein and phosphorylation characteristics in breast cancer and paired metastatic lymph nodes
    Linhui Zhai, C. Liu, Lei Zhao, Le-Wei Zheng, Chengyu Chu, Hu Hong, Yuwen Cai, Lie Chen, Yi-Ming Liu, Yu Wang et al. · 2026 · Protein & Cell
29. Global impact of germline structural variation on the cancer proteome
    Fengju Chen, Yiqun Zhang, Luis F. Paulin, Darshan Shimoga Chandrashekar, Sooryanarayana Varambally, Fritz Joachim Sedlazeck, Chad J. Creighton · 2026 · Nature Communications
30. The evolving role of OMICS in gastrointestinal tumor biology and clinical practice
    Qi Li, Junfeng Zhang, Junli Chen, Qiang Zhang, Ruihan Liu, Jialin Zhu, Yi Qing, Xi Wei, Jianpeng Sheng · 2026 · Molecular Cancer
31. Mass spectrometry-based proteomics delivers in-depth proteome profiling of FFPE lung cancer biopsies from single glass slides
    Olena Berkovska, Igor Schliemann, Georgios Mermelekas, Nazlı Ezgi Özkan, Mahnaz Nikpour, Vilde Drageset Haakensen, Åslaug Helland, Janne Lehtiö, Lukas M. Orre · 2026 · npj Precision Oncology
32. Pathogenesis of diffuse large B cell lymphoma proteogenotypes
    Julius Christoph Enssle, Björn Häupl, Arber Qoku, Boya Wang, George W. Wright, Sharon Barrans, Yulai Zhou, Matthew A. Care, Cathy Burton, Caitlin K. Gribbin et al. · 2026 · Cancer Cell
33. PAMP orchestrates proline metabolic rewiring to suppress LUAD via PYCR1 inhibition
    Y L Ma, Jiani Yi, Chengcai Zheng, Juze Yang, Li J, Mengqian Yu, Xinyi Qian, Jiayi Ren, Xiaofan Wu, Yan Lü et al. · 2026 · EMBO Molecular Medicine
34. PCLassoLog: A protein complex-based, group Lasso-logistic model for cancer classification and risk protein complex discovery
    Wei Wang, Haiyan Yuan, Junwei Han, Wei Liu · 2022 · Computational and Structural Biotechnology Journal
35. PhosphoDisco: A Toolkit for Co-regulated Phosphorylation Module Discovery in Phosphoproteomic Data
    Tobias Schraink, Lili M. Blumenberg, Grant A. Hussey, Sabrina George, Brecca Miller, Nithu Mathew, Tania J González-Robles, Vladislav O. Sviderskiy, Thales Y. Papagiannakopoulos, Richard Possemato et al. · 2023 · Molecular & Cellular Proteomics
36. Revealing the Preventable Effects of Fu-Zheng-Qu-Xie Decoction against Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma Based on Network Pharmacology Coupled with Metabolomics Analysis
    Yixi Zhang, Kai Ma, Lei Jiang, Lili Xu, Yingbin Luo, Jianchun Wu, Yan Li · 2023 · ACS Omega
37. Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer
    Jing Lin, Mengen Zhai, Meirui Qian, Yiming Li, Mingwei Han, Kun Wang, Wan Huang, Gang Nan, Jian‐Li Jiang · 2023 · Cell Death Discovery
38. A platform-independent AI tumor lineage and site (ATLAS) classifier
    Nicholas Robert Rydzewski, Yue Shi, Chenxuan Li, Matthew R. Chrostek, Hamza Bakhtiar, Kyle T. Helzer, Matthew L. Bootsma, Tracy J. Berg, Paul M. Harari, John M. Floberg et al. · 2024 · Communications Biology
39. Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation
    Theofanis Vavilis, Maria Louiza Petre, Giannis Vatsellas, Alexandra Ainatzoglou, Εleni Stamoula, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas, Ioannis N. Vamvakaris, Ioannis Gkiozos et al. · 2024 · Cancers
40. Antisense-mediated splicing correction as a therapeutic approach for p53 K120R mutation
    Doyeong Kim, Sang‐Min Park, Seo-Young Lee, Jinchul Kim, Han-Byul Jung, Young Sook Kim, Sun‐Ku Chung · 2024 · BMB Reports
41. Advancing Thoracic Surgical Oncology in the Era of Precision Medicine
    Giacomo Argento, Erino Angelo Rendina, Giulio Maurizi · 2025 · Cancers
42. Causal Inference and Annotation of Phosphoproteomics Data in Multiomics Cancer Studies
    Qun Dong, Minjia Tan, Yingchun Zhou, Yue Zhang, Jing Li · 2025 · Molecular & Cellular Proteomics
43. Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer
    Yasunobu Mano, Yuka Igarashi, KEISUKE KOMORI, ITARU HASHIMOTO, Hayato Watanabe, Kosuke Takahashi, Kazuki Kano, Hirohito Fujikawa, Takanobu Yamada, Hidetomo Himuro et al. · 2025 · Frontiers in Immunology
44. Immune landscape and novel therapeutic targets of epidermal growth factor receptor and anaplastic lymphoma kinase wild type never-smoker lung adenocarcinoma
    Wonyoung Choi, Wonyeop Lee, Young-Wook Kim, Sang-Jin Lee, Geon Kook Lee, Seung-Jin Park, Shinyeong Ju, Seon‐Young Kim, Cheolju Lee, Ji‐Youn Han · 2025 · Lung Cancer
45. Sex differences in the cancer proteome
    Chenghao Zhu, Nicole Zeltser, Jieun Oh, Constance H. Li, Paul Christopher Boutros · 2026 · BMJ Oncology
46. Adverse predictive value of ASPM on lung adenocarcinoma overall survival depended on chemotherapy status
    Yan Zheng, Baichen Sun, Zhiling Qu · 2025 · Future Science OA
47. Ontolomics-P: Advancing Proteomics Data Interpretation through GPT-4o Reannotated Topic Ontology and Data-Driven Analysis
    Yin Yang, Shisheng Wang, Yuzhe Chen, Xinyuan Wang, Wei Jiang, Youmei Jin, Wenjuan Zeng, Dongbo Wu, Bairong Shen, Hao Yang · 2025 · Analytical Chemistry
48. High KYNU Expression Is Associated with Poor Prognosis, KEAP1/STK11 Mutations, and Immunosuppressive Metabolism in Patient-Derived but Not Murine Lung Adenocarcinomas
    Ling Cai, Thomas J. Rogers, Reza Mousavi Jafarabad, Hieu S. Vu, Chendong Yang, Nicole Novaresi, Ana Galán‐Cobo, Luc Girard, Edwin Justin Ostrin, Johannes Francois Fahrmann et al. · 2025 · Cancers
49. Clinical and molecular implications of cGAS/STING signaling in checkpoint inhibitor immunotherapy
    Hao Hui Chen, Yang Zhong, Rongjie Feng, Xingyu Zhu, Kang Xu, Mingjie Kuang, Wei Chong · 2025 · Frontiers in Molecular Biosciences
50. Identification of crucial genes sustaining the curled leaf phenotype in perennial transgenic poplar via advanced proteomic and phosphoproteomic analyses
    Z.J Wu, Chao-nan Guan, Ye-Bo Yang, Yuexuan Zhang, Meng-Yu Gai, Shiyi Wang, Xiu-Xing Zhang, Yuwen Wang, Jing Xue, Bo-Hao Duan et al. · 2025 · Journal of Proteomics
51. SRPS: Survival Reinforced Transfer Learning for Multicentric Proteomic Subtyping and Biomarker Discovery
    Linhai Xie, Pei Jiang, Cheng Chang · 2025 · Genomics Proteomics & Bioinformatics
52. Lymphopenia, IL6, and CCL2 after thoracic radiotherapy predict poor prognosis in patients with lung cancer
    Jenny Ling‐Yu Chen, Yu‐Sen Huang, Yong-Han Su, Ching‐Ying Kuo, Yeun‐Chung Chang · 2025 · Journal of the Formosan Medical Association
53. Protocol for tandem enrichment of ubiquitinated, phosphorylated, and glycosylated peptides with SCASP-PTM
    Zhan-Peng Lin, Yuyang Wang, Chengwen Wen, Kaijie Zhang, Xiangyu Chen, Liang Xu, Wan-Yue Luo, Changchuan Xie, Chuan‐Qi Zhong · 2025 · STAR Protocols
54. Assessing Long-Term Stored Tissues for Multi-Omics Data Quality and Proteogenomics Suitability
    Kyu Jin Song, Minsuh Kim, Yong Jin Heo, Kyung-Cho Cho, Jae-Won Oh, Dae Ho Kim, Chanwoong Hwa, Yeji Do, Seunghyuk Choi, Hee Sang Hwang et al. · 2025 · Journal of Proteome Research
55. Melanin metabolism mediated via tyrosinase protein involved in red shell coloration of hard clam, Meretrix meretrix
    Lulu Fu, Heming Shi, Yinghui Dong, Zhihua Lin, Yongbo Bao, Haimin Chen, Hanhan Yao · 2025 · Comparative Biochemistry and Physiology Part D Genomics and Proteomics
56. Emerging Omic-derived biomarkers for early diagnosis of non-small cell lung Cancer
    Xiaoyu Wei, Mingyue Xu, Yi-Chen Wang, Haitao Huang, Qi Chen, Baofu Chen, Xiao-Hong Bao, Ji‐Cheng Li · 2025 · Clinica Chimica Acta
57. Predictions of Response in Non-small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Using Clinical Data, Deep Learning, and Radiomics.
    Chunxiao Wang, Yu-Xin Li, Yang Ji, Kang Yu, Chunhui Qin, Ling Liu, Yun-Jia Shuai, Jia-Hui Chen, Ao Li, Tong Zhang · 2025 · Academic Radiology
58. Elastic Net Models Based on DNA Copy Number Variations Predicts Clinical Features, Expression Signatures, and Mutations in Lung Adenocarcinoma
    Yi Xiang, Xiaohuan Zou, Huaqiu Shi, Xueming Xu, Caixia Wu, Wenjuan Zhong, Jinfeng Wang, Wenting Zhou, Xiaoli Zeng, Miao He et al. · 2021 · Frontiers in Genetics
59. Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
    Dave Mitchell, Allison L. Hunt, Kelly A. Conrads, Brian L. Hood, Sasha C. Makohon‐Moore, Christine Rojas, G. Larry Maxwell, Nicholas W. Bateman, Thomas P. Conrads · 2022 · Journal of Visualized Experiments
60. Novel Online Three-Dimensional Separation Expands the Detectable Functional Landscape of Cellular Phosphoproteome
    Chaewon Kang, Sunghyun Huh, Dowoon Nam, Hokeun Kim, Jiwon Hong, Daehee Hwang, Sang‐Won Lee · 2022 · Analytical Chemistry
61. Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma
    Yaxin Chen, Lei Xia, Yuxuan Peng, Gang Wang, Liyun Bi, Xue Xiao, Cui Li, Weimin Li · 2022 · Frontiers in Oncology
62. Protocol to analyze dysregulation of the eIF4F complex in human cancers using R software and large public datasets
    Su Wu, Gerhard Wagner · 2022 · STAR Protocols
63. Proteogenomics Reveal the Overexpression of HLA-I in Cancer
    Ying Wang, David Fenyö · 2023 · Journal of Proteome Research
64. Bioinformatics analysis of NSCLC multi-omics data
    Janne Lehtiö, Taner Arslan, Ioannis Siavelis, Yanbo Pan, Fabio Socciarelli, Olena Berkovska, Husen Muhammad Umer, Georgios Mermelekas, Mohammad Pirmoradian, Mats Jönsson et al. · 2021 · Research Square
65. Unsaturated fatty acid alters the immune response in non-small cell lung adenocarcinoma through regulation of HMGB1 trafficking
    Breanna Cole-Skinner, Nicole M. André, Zachary Blankenheim, Kate M. Root, Glenn E. Simmons Jr. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
66. Illuminating the Dark Cancer Phosphoproteome Through a Machine-Learned Co-Regulation Map of 26,280 Phosphosites
    Wen Jiang, Eric J. Jaehnig, Yuxing Liao, Tomer M. Yaron-Barir, Jared Lee Johnson, Lewis C. Cantley, Bing Zhang · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
67. Amino acid substitutomics: profiling amino acid substitutions at proteomic scale unveils biological implication and escape mechanism in cancer
    Peize Zhao, Shengzhi Lai, Shuaijian Dai, Chen Zhou, Ning Li, Weichuan Yu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
68. Drug Response Modeling across Cancers: Proteomics vs. Transcriptomics
    Zetian Zheng, Lei Huang, Fuzhou Wang, Linjing Liu, Jixiang Yu, Weidun Xie, Xingjian Chen, Xiangtao Li, Ka‐Chun Wong · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
69. Identifying Sex Differences in Lung Adenocarcinoma Using Multi-Omics Integrative Protein Signaling Networks
    Chen Chen, Enakshi Saha, Jonas Fischer, Marouen Ben Guebila, Viola Fanfani, Katherine Hoff Shutta, Megha Padi, Kimberly Glass, Dawn Lisa DeMeo, Camila M. Lopes‐Ramos et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
70. Complementary modes of resistance to EGFR TKI in lung adenocarcinoma through MAPK activation and cellular plasticity
    Matthew Zatzman, Àlvaro Quintanal-Villalonga, Sohrab Salehi, Nicholas Ceglia, Jake June-Koo Lee, Amanda Pupo, Christina J. Falcon, Nicole Rusk, Ignas Masilionis, Ojasvi Chaudhary et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
71. Multi-omics of sorafenib responsiveness in HCC patients
    Eva Dazert, Tuyana Boldanova, Charlotte K.Y. Ng, Marco Colombi, Stefan F. Wieland, George Rosenberger, Francesco Marass, Salvatore Piscuoglio, Niko Beerenwinkel, Luigi Terracciano et al. · 2025 · medRxiv
72. JAK1/2 Inhibition Delays Cachexia and Improves Survival through Increased Food Intake
    Ezequiel Dantas, Anirudh Murthy, Jeshua Kim, Tanvir Ahmed, Mujmmail Ahmed, Tiffany Perrier, Shakti Ramsamooj, Isaac Nathoo, Lucas Kniess Debarba, André Lima Queiroz et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
73. Relationship between early lung adenocarcinoma and multiple driving genes based on artificial intelligence medical images of pulmonary nodules
    Yajun Yin, Jiawei Lu, Jichun Tong, Youshuang Cheng, Ke Zhang · 2023 · Frontiers in Genetics
74. Depiction of neuroendocrine features associated with immunotherapy response using a novel one-class predictor in lung adenocarcinoma
    Hao Liu, Yan Han, Zhantao Liu, Liping Gao, Tienan Yi, Yuandong Yu, Yu Wang, Ping Qu, Longchao Xiang, Yong Li · 2023 · Discover Oncology
75. A novel subtype based on driver methylation–transcription in lung adenocarcinoma
    Xin Wang, Zhenyi Xu, Shuang Zhao, Jiali Song, Yipei Yu, Han Yang, Yan Hou · 2024 · Journal of Cancer Research and Clinical Oncology
76. Proteomics in the Pharmaceutical Industry: Prospects and Challenges
    Dhara Patel, Vivek Patel, Grishma Patel, Jayvadan K. Patel · 2024 · Springer eBooks
77. RNA sequencing identifies lung cancer lineage and facilitates drug repositioning
    Longjin Zeng, Long-Yao Zhang, Ling-Chen Li, Xing-Yun Liao, Chenrui Yin, Lin-Cheng Zhang, Xie-Wan Chen, Jian-Guo Sun · 2023 · bioRxiv
78. Prediction and analysis of the tumor invasiveness of pulmonary ground-glass nodules based on metabolomics
    Zixu Liu, Ling Wang, Shugeng Gao, Qi Xue, Fengwei Tan, Zhili Li, Yushun Gao · 2024 · Clinical and Experimental Medicine
79. Inferring kinase–phosphosite regulation from phosphoproteome-enriched cancer multi-omics datasets
    Haoyang Cheng, Zhuoran Liang, Yijin Wu, Jiamin Hu, Bijin Cao, Zekun Liu, Bo Liu, Han Cheng, Zexian Liu · 2025 · Briefings in Bioinformatics
80. Silencing GGH induces autophagy by increasing folate stress and production of NADH
    Yu Li, Yuhui Du, Sijie Chen, Zhangrong Xie, Xinrui Li, Baoyue Lin, Zhiqing Zhou, Huijie Zhao, Guoan Chen · 2025 · Journal of Molecular Cell Biology
81. Small molecules in lung cancer targeted therapy: a two-decade bibliometric analysis and visualization (2005–2024)
    Mengyao Sun, Yue Yin, Daming Chen, Zejun Jia · 2025 · Clinical Cancer Bulletin
82. Identifying the crucial oncogenic mechanisms of DDX56 based on a machine learning-based integration model of RNA-binding proteins
    Hui Jiang, Haotian Zheng, Xinjie Zhao, Yunzhi Xiang, Jiahao Li, Kai Wang, Guanghui Wang, Jiajun Du · 2025 · npj Precision Oncology
83. OCIAD2 Promotes Cancer Progression via Metabolic Reprogramming in Lung Adenocarcinoma
    Yi-Hui Huang, Wen‐Hsin Chang, Chi-Ya Shen, Kang‐Yi Su, Gee‐Chen Chang, Jin‐Shing Chen, Wen-Yao Lee, Yu‐Ju Chen, Sung‐Liang Yu · 2025 · Journal of Proteome Research
84. The GGH/HuR Complex Binds and Stabilizes mRNAs to Maintain Tumor Cell Cycle and DNA Replication
    Yu Li, Xinrui Li, Yuhui Du, Sijie Chen, Xiaoniu He, Zhangrong Xie, Zhiqing Zhou, Huijie Zhao, Xiaofei Zeng, Guoan Chen · 2025 · Advanced Science
85. Stem-like CD4+ T cells mediate T-cell state transitions to enhance tumor control and immunotherapy response
    Mamali Das, Chandramohan Kiruthiga, K. T. Nachammai, Dipali Desai, William Chi Shing Cho, Chandrabose Selvaraj, Langeswaran Kulanthaivel · 2025 · International Immunopharmacology
86. Novel Evolutionarily Conserved Oncogene COA4 is Driven by KRAS Mutant and Promotes Cancer Metastasis Through Dual Mitochondrial Metabolism‐Dependent and ‐Independent Mechanisms
    Xingzhao Ji, Weiying Zhang, Fuyuan Xue, Jiazhen Zeng, Qinghua Zhao, Xiaoming Sun, Jian Hong Sun, Heng Zhou, Quanlin Xu, Guoyuan Ma et al. · 2025 · Advanced Science
87. ConVLM: Context-guided vision-language model for fine-grained histopathology image classification
    Anabia Sohail, Iyyakutti Iyappan Ganapathi, Basit Alawode, Sajid Javed, Mohammed Bennamoun, Arif Mahmood · 2025 · Information Fusion
88. Toward real clinical utility: leveraging comprehensive cancer proteomic datasets for clinical insight
    Karin Rodland, Bing Zhang · 2025 · Expert Review of Proteomics
89. The frequency of core MMR gene alterations in lung cancer and their clinical characterization: A comprehensive study of over 26,000 cases
    Li Hu, Yuquan Pei, Xiaofeng Wang, Qian Liu, Wenli Cao, Yanfei Liu, Furong Kou, Xingyu Liao, Yaxin Zhang, Jinqiu Rui et al. · 2025 · The Innovation Medicine
90. SpecQuality: A Tool for Reliable Spectral Quality Assessment in Proteomics and Proteogenomics
    Alka Yadav, Uma Dhawan · 2025 · Journal of the American Society for Mass Spectrometry
91. ProteoformDB: A Built-In Application to Generate Proteoform Database
    Trung Hoàng, Yingwei Hu, Hui Zhang · 2025 · Journal of Proteome Research
92. Comprehensive analysis of malignant subtypes of lung adenocarcinoma based on multi-omics landscape and functional validation of prognostic biomarker BAIAP2L2
    Bowei Jiang, Yuan Gan, Wanshuo Wei, Meichun Yang, Jiahui Long, Xiujuan He, Hanbo Yu, Jianjun Wen, Zhongheng Wei, Qijun Long · 2025 · Scientific Reports
93. Panorama: a database for the oncogenic evaluation of somatic mutations in pan-cancer
    Seung-Jin Park, Seon‐Young Kim · 2026 · Database
94. Spectronaut and DIA-NN: A Comparison of their Performance in the Analysis of Lung Adenocarcinoma Biopsies
    Zhaoyan Yu, An Du, Xiaona Xu, Yinan Li, Xiaoxue Ma, Wenyang Zhang, Yunzeng Zhang, Ivan Keung Chu, K. W. Michael Siu · 2026 · ACS Omega
95. Combination therapy with lorlatinib and mitogen-activated protein kinase pathway inhibition in previously treated ALK- or ROS1-rearranged lung cancer
    Jaime Laurel Schneider, Alona Muzikansky, Elizabeth Krueger, Justin F. Gainor, Jessica J. Lin, Susan Symes, Alice Tsang Shaw, Ibiayi Dagogo‐Jack · 2026 · Lung Cancer
96. Emerging roles of artificial intelligence/machine learning (AI/ML) towards new understandings in molecular crosstalk between circRNA–CUL3–TKI to resensitize chemoresistant cancers
    Pranjali Dutta, Samiksha Middya, Siddharth Shome, Manshi Kumari Gupta, Poobana Dharmalingam, Chinnappan Sudandiradoss · 2026 · Molecular and Cellular Probes
97. Molecular Classification of Patients With COVID‐19 Based on Transcriptional Profiling
    Hongyu Liu, Ying Zheng, Xiaoyan Deng, Mengxue Li, Di He, Wenting Zuo, Yitian Xu, Xuhui Shen, Haibo Li, Bin Cao · 2026 · Influenza and Other Respiratory Viruses
98. Multiomics assessment of lung adenocarcinoma subtypes defined through tumor purity-adjusted DNA methylation
    Deborah F. Nacer, Elsa Arbajian, Srinivas Veerla, Mattias Aine, Mats Jönsson, Frida Rosengren, Anna Karlsson, Annette Salomonsson, Sofi Isaksson, Maria Planck et al. · 2026 · Genome Medicine
99. Pan-cancer analysis of PDZK1IP1 reveals its role in tumorigenesis and tumor immunity: focused validation in thyroid carcinoma
    Chenchen Geng, Xiaoqian Gao, Yali Le, Shuzhen Zhu, GuangHui Zhao, Ping Zhang · 2026 · Hereditas
100. Proteomic characterization of small cell lung cancer uncovers innate-adaptive immune dynamics and immunotherapeutic vulnerabilities
     Zicheng Zhang, Siqi Bao, Ruanqi Chen, Li Ling Liu, Fan Yang, Jiyan Dong, Xujie Sun, Lin Yang, Meng Zhou, Jianming Ying · 2026 · Genes & Diseases